TY  - GEN
AU  - Villa-Morales, María
AU  - Pérez-Gómez, Laura
AU  - Pérez-Gómez, Eduardo
AU  - López-Nieva, Pilar
AU  - Fernandez-Navarro, Pablo L
AU  - Santos, Javier
PY  - 2023
DO  - 10.3390/ijms241210350
UR  - http://hdl.handle.net/20.500.12105/16486
AB  - The standard-of-care treatment of T-cell acute lymphoblastic leukaemia (T-ALL) with chemotherapy usually achieves reasonable rates of initial complete response. However, patients who relapse or do not respond to conventional therapy show dismal...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - T-cell acute lymphoblastic leukaemia (T-ALL)
KW  - NRF2 (nuclear factor erythroid 2-related factor 2)
KW  - Prognostic biomarker
KW  - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
KW  - Humans
KW  - NF-E2-Related Factor 2
KW  - Prognosis
KW  - Phosphatidylinositol 3-Kinases
KW  - Neoplasm Recurrence, Local
KW  - T-Lymphocytes
TI  - Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia
TY  - research article
ER  -